Welcome to our dedicated page for OptimumBank Holdings SEC filings (Ticker: OPHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on OptimumBank Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into OptimumBank Holdings's regulatory disclosures and financial reporting.
OptimumBank Holdings, Inc. (NYSE American: OPHC) filed Prospectus Supplement No. 1 to its August 20, 2024 at-the-market (ATM) prospectus, updating investors on its common-stock issuance program.
- Amended Sales Agreement: On July 1, 2025, the company added A.G.P./Alliance Global Partners as a second sales agent alongside Compass Point Research & Trading, LLC. Both firms may act as agent or principal under the "Amended Sales Agreement."
- Offering Size: The total ATM capacity remains $25 million. Through June 27, 2025, OPHC has already sold $9,569,512, leaving $15,430,488 available for future issuance.
- Sales Mechanics: • Shares will be sold from time to time by either agent via ordinary-broker transactions or other methods qualifying as Rule 415 "at the market" offerings. • The company may set daily share or dollar limits and minimum acceptable prices. • Either party may suspend or terminate sales at any time.
- Compensation & Costs: Agents earn up to 2.0 % of gross proceeds per share sold and are eligible for reimbursement of out-of-pocket expenses capped at $55,000. All commissions are deemed underwriting discounts; the company provides customary indemnification.
- Settlement & Reporting: Trades settle T+1 through DTC. OPHC will disclose quarterly the number of shares sold, net proceeds and total agent compensation.
- Risk Notice: The supplement re-affirms that investing in OPHC common stock "involves a high degree of risk," directing investors to previously disclosed Risk Factors.
- Trading Snapshot: Last reported share price on June 27, 2025 was $4.51.
In sum, the filing primarily extends distribution capacity by engaging a second agent and confirms the remaining authorization to raise approximately $15.4 million of equity capital, subject to market conditions.